{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:44:19Z","timestamp":1787010259684,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe asthma exacerbations in pediatric patients occur frequently and can require pediatric intensive care unit (PICU) admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine if early administration of intravenous magnesium sulfate (IVMg) to pediatric patients experiencing severe asthma exacerbations, defined as a respiratory clinical score (RCS) of 9 to 12, resulted in fewer PICU admissions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective chart review of pediatric patients aged from 2 to 17 years presenting with a severe asthma exacerbation to a single tertiary care pediatric emergency department. Univariable and multivariable logistic regression analyses were used to determine if admission to the PICU was associated with early IVMg treatment, within 60 minutes of registration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1911 patients were included in the study, of which 1541 received IVMg. The average time to IVMg was 79 minutes, with 35% of the patients receiving it within 60 minutes of arrival. Two hundred forty-eight (13%) were admitted to the PICU, 641 (34%) were admitted to the general inpatient floor, and 1022 (53%) were discharged home. Factors associated with increased odds ratio (OR) of PICU admission were: early IVMg (OR, 1.63; 95% CI: 1.16\u20132.28), arrival mode to the emergency department via ambulance (OR, 2.23; 95% CI: 1.45\u20133.43), history of PICU admission for asthma (OR, 1.73; 95% CI: 1.22\u20132.44), and diagnosis of status asthmaticus (OR, 8.88; 95% CI: 3.49\u201330.07). Calculated OR of PICU admission subcategorized by RCS for early IVMg patients, after controlling for PICU risk factors, are as follows: RCS 9 (reference), RCS 10 (OR, 2.52; 95% CI: 0.89\u20132.23), RCS 11 (OR, 2.19; 95% CI: 1.3\u20133.70), and RCS 12 (OR, 4.12; 95% CI: 2.13\u20137.95).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early administration of IVMg to pediatric patients experiencing severe asthma exacerbations does not result in fewer PICU admissions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pec.0000000000002890","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T15:35:31Z","timestamp":1675352131000},"page":"524-529","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Early Intravenous Magnesium Sulfate Administration in the Emergency Department for Severe Asthma Exacerbations"],"prefix":"10.1097","volume":"39","author":[{"given":"Brian L.","family":"Forster","sequence":"first","affiliation":[{"name":"Division of Emergency Services, Department of Pediatrics, The University of Tennessee Health Science Center and Le Bonheur Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fridtjof","family":"Thomas","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Preventative Medicine, The University of Tennessee Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, The University of Tennessee Health Science Center and Le Bonheur Children's Hospital, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Snider","sequence":"additional","affiliation":[{"name":"Division of Emergency Services, Department of Pediatrics, The University of Tennessee Health Science Center and Le Bonheur Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,8]]},"reference":[{"key":"bib2-20250504","first-page":"1","article-title":"Summary health statistics for US children: National Health Interview Survey, 2012","volume":"10","year":"2013","journal-title":"Vital Health Stat"},{"key":"bib3-20250504","doi-asserted-by":"crossref","first-page":"e091","DOI":"10.1097\/pq9.0000000000000091","article-title":"Implementing a standardized clinical pathway leads to reduced asthma admissions and health care costs","volume":"3","year":"2018","journal-title":"Pediatr Qual Saf"},{"key":"bib4-20250504","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ppul.10425","article-title":"Use of a respiratory clinical score among different providers","volume":"37","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"bib6-20250504","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/adc.2004.050005","article-title":"A meta-analysis on intravenous magnesium sulphate for treating acute asthma","volume":"90","year":"2005","journal-title":"Arch Dis Child"},{"key":"bib7-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cpem.2018.02.002","article-title":"What is the role for magnesium to treat severe pediatric asthma exacerbations","volume":"19","year":"2018","journal-title":"Clin Pediatr Emerg Med"},{"key":"bib8-20250504","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/PEC.0000000000000909","article-title":"Intravenous and nebulized magnesium sulfate for treating acute asthma in children: a systematic review and meta-analysis","volume":"34","year":"2018","journal-title":"Pediatr Emerg Care"},{"key":"bib9-20250504","first-page":"63","article-title":"Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane reviews","volume":"38","year":"2021","journal-title":"Paediatr Respir Rev"},{"key":"bib10-20250504","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1553-2712.2010.00913.x","article-title":"North American practice patterns of intravenous magnesium therapy in severe acute asthma in children","volume":"17","year":"2010","journal-title":"Acad Emerg Med"},{"key":"bib11-20250504","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jpeds.2020.01.062","article-title":"Intravenous magnesium in asthma pharmacotherapy: variability in use in the PECARN registry","volume":"220","year":"2020","journal-title":"J Pediatr"},{"key":"bib12-20250504","first-page":"CD011050","article-title":"Intravenous magnesium sulfate for treating children with acute asthma in the emergency department","volume":"4","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"bib13-20250504","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1542\/hpeds.2020-004770","article-title":"Intravenous magnesium and hospital outcomes in children hospitalized with asthma","volume":"11","year":"2021","journal-title":"Hosp Pediatr"},{"key":"bib14-20250504","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1097\/PEC.0000000000002269","article-title":"The impact of terbutaline as adjuvant therapy in the treatment of severe asthma in the pediatric emergency department","volume":"38","year":"2022","journal-title":"Pediatr Emerg Care"},{"key":"bib15-20250504","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jpeds.2013.05.002","article-title":"Childhood asthma hospitalizations in the United States, 2000\u20132009","volume":"163","year":"2013","journal-title":"J Pediatr"},{"key":"bib16-20250504","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-3476(96)70023-9","article-title":"Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial","volume":"129","year":"1996","journal-title":"J Pediatr"},{"key":"bib17-20250504","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archpedi.154.10.979","article-title":"Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma","volume":"154","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"bib18-20250504","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000506595","article-title":"Efficacy of magnesium sulfate treatment in children with acute asthma","volume":"29","year":"2020","journal-title":"Med Princ Pract"},{"key":"bib19-20250504","first-page":"389","article-title":"Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy","volume":"34","year":"1997","journal-title":"Indian Pediatr"},{"key":"bib20-20250504","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1067\/mem.2000.111060","article-title":"A randomized trial of magnesium in the emergency department treatment of children with asthma","volume":"36","year":"2000","journal-title":"Ann Emerg Med"},{"key":"bib21-20250504","doi-asserted-by":"crossref","first-page":"1701579","DOI":"10.1183\/13993003.01579-2017","article-title":"Intravenous magnesium sulfate for acute wheezing in young children: a randomised double-blind trial","volume":"51","year":"2018","journal-title":"Eur Respir J"},{"key":"bib22-20250504","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jaip.2021.11.028","article-title":"Prospective observational study of clinical outcomes after intravenous magnesium for moderate and severe acute asthma exacerbations in children","volume":"10","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"bib23-20250504","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(15)00156-7","article-title":"Risk factors for asthma: is prevention possible?","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"bib25-20250504","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/acem.13281","article-title":"Pediatric emergency department utilization and reliance by insurance coverage in the United States","volume":"24","year":"2017","journal-title":"Acad Emerg Med"},{"key":"bib26-20250504","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1377\/hlthaff.2017.0218","article-title":"The uninsured do not use the emergency department more-they use other care less","volume":"36","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"bib27-20250504","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1385\/CRIAI:31:2:181","article-title":"Recovery from bronchoconstriction and bronchodilator tolerance","volume":"31","year":"2006","journal-title":"Clin Rev Allergy Immunol"},{"key":"bib28-20250504","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1399-3003.1999.14b08.x","article-title":"Tolerance to beta-agonists during acute bronchoconstriction","volume":"14","year":"1999","journal-title":"Eur Respir J"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000002890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T14:09:31Z","timestamp":1746367771000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000002890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,8]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000002890","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,8]]}}}